Cortexyme gathers $76M to fund efficacy study of antibiotic for Alzheimer’s
Cortexyme gathers M to fund efficacy study of antibiotic for Alzheimer’s Alzheimer’s disease startup Cortexyme was able to round up $76 million in funding for a potentially first-in-class treatment, while […]